Quadrant Capital Group Portfolio holdings
Constellation Wealth Advisors, the trading name of Quadrant Capital Group, is a wealth manager for high net worth individuals and their trusts and estates, with a private capital platform of its own. Patrick Lafley and John Williams, who had spent years as financial advisors at big banks and institutions, founded it in 2009 to give families with complex finances a better kind of wealth management. In January 2026 it named Kelly Bonnell chief executive and David Snopkowski chief investment officer. Each year it picks eight to twelve private investments across private equity, venture capital, real assets and private credit.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kroger
KR
|
+$606K |
| 2 |
TotalEnergies
TTE
|
+$366K |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$234K |
| 4 |
DXC Technology
DXC
|
+$201K |
| 5 |
Fifth Third Bancorp
FITB
|
+$196K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.39M |
| 2 |
Vanguard Information Technology ETF
VGT
|
+$705K |
| 3 |
iShares Russell 2000 Growth ETF
IWO
|
+$517K |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$374K |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$368K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.44% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.36% |
| 4 | Technology | 8.5% |
| 5 | Consumer Staples | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Procter & Gamble
PG
$391B
| $7.72M | 3.41% |
116,695
-15,756
| -12% | -$1.39M |
2015 Q2
8 quarters
|
|
2
iShares Core MSCI Emerging Markets ETF
IEMG
$145B
| $6.34M | 2.8% |
127,167
+798
| +0.6% | +$39.4K |
2016 Q2
4 quarters
|
|
3
Vanguard Morningstar Total Stock Market ETF
VTI
$686B
| $6.3M | 2.78% |
50,629
| – | – |
2015 Q2
8 quarters
|
|
4
iShares Russell 1000 ETF
IWB
$47.6B
| $5.42M | 2.39% |
40,123
-1,020
| -2% | -$136K |
2015 Q2
8 quarters
|
|
5
Apple
AAPL
$5.06T
| $4.16M | 1.84% |
124,664
-3,088
| -2% | -$114K |
2015 Q2
8 quarters
|
|
6
American Express
AXP
$217B
| $3.56M | 1.57% |
42,708
-386
| -0.9% | -$30.5K |
2015 Q2
8 quarters
|
|
|
7
iShares Core S&P Small-Cap ETF
IJR
$106B
| $3.5M | 1.55% |
50,178
-5,402
| -10% | -$374K |
2015 Q2
8 quarters
|
|
|
8
iShares Russell 2000 Growth ETF
IWO
$14.1B
| $3.21M | 1.42% |
19,055
-3,144
| -14% | -$517K |
2015 Q2
8 quarters
|
|
|
9
iShares MSCI ACWI ETF
ACWI
$32.2B
| $3.11M | 1.38% |
47,693
+3,609
| +8% | +$234K |
2015 Q2
8 quarters
|
|
|
10
Vanguard Real Estate ETF
VNQ
$38.9B
| $3.06M | 1.35% |
36,816
-4,414
| -11% | -$368K |
2015 Q2
8 quarters
|
|
11
iShares Core S&P 500 ETF
IVV
$870B
| $3.05M | 1.35% |
12,550
| – | – |
2015 Q2
8 quarters
|
|
12
Home Depot
HD
$350B
| $2.98M | 1.32% |
19,697
+94
| +0.5% | +$14.4K |
2015 Q2
8 quarters
|
|
13
iShares Russell Mid-Cap ETF
IWR
$58.3B
| $2.59M | 1.15% |
54,204
+3,612
| +7% | +$171K |
2015 Q2
8 quarters
|
|
14
DELISTED
Meridian Bioscience Inc
VIVO
| $2.49M | 1.1% |
158,706
+223
| +0.1% | +$3.21K |
2017 Q1
1 quarter
|
|
15
iShares Russell 1000 Growth ETF
IWF
$117B
| $2.31M | 1.02% |
77,940
| – | – |
2015 Q2
8 quarters
|
|
16
US Bancorp
USB
$94.7B
| $2.22M | 0.98% |
43,409
-1,047
| -2% | -$53.9K |
2015 Q2
8 quarters
|
|
17
ExxonMobil
XOM
$671B
| $2.16M | 0.96% |
29,311
+1,857
| +7% | +$152K |
2015 Q2
8 quarters
|
|
18
iShares Russell 1000 Value ETF
IWD
$84.7B
| $2.09M | 0.92% |
18,020
-345
| -2% | -$39.7K |
2015 Q2
8 quarters
|
|
19
Microsoft
MSFT
$3.96T
| $1.99M | 0.88% |
30,375
-820
| -3% | -$56.3K |
2015 Q2
8 quarters
|
|
20
Becton Dickinson
BDX
$57.9B
| $1.92M | 0.85% |
10,209
+46
| +0.5% | +$8.4K |
2015 Q2
8 quarters
|
|
21
JPMorgan Chase
JPM
$908B
| $1.82M | 0.81% |
20,949
+551
| +3% | +$47.5K |
2015 Q2
8 quarters
|
|
22
Johnson & Johnson
JNJ
$676B
| $1.63M | 0.72% |
12,916
-324
| -2% | -$41.3K |
2015 Q2
8 quarters
|
|
23
Alphabet (Google) Class A
GOOGL
$3.53T
| $1.6M | 0.71% |
38,540
-20
| -0.1% | -$936 |
2015 Q4
6 quarters
|
|
24
GE Aerospace
GE
$351B
| $1.51M | 0.67% |
12,317
-653
| -5% | -$89.5K |
2015 Q2
8 quarters
|
|
25
Pfizer
PFE
$167B
| $1.5M | 0.66% |
49,096
+1,011
| +2% | +$31.9K |
2015 Q2
8 quarters
|
|
Similar funds
Quadrant Capital Group's Q2 2017 Portfolio in Review
As of Q2 2017, Quadrant Capital Group held 2,289 positions worth $226M, down 0.6% from $228M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Quadrant Capital Group's Q2 2017 filing shows 104 new, 642 increased, 479 reduced and 97 closed positions. Its largest new stake was DXC Technology: 3,036 shares worth $180K. The largest sale was Procter & Gamble, an estimated $1.39M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, up from 37% a quarter earlier, followed by Financials and Healthcare.
- Quadrant Capital Group's largest Q2 2017 buy was DXC Technology: 3,036 shares worth $180K.
- Quadrant Capital Group added most to Kroger in Q2 2017, an estimated $606K increase.
- Quadrant Capital Group's biggest Q2 2017 reduction was Procter & Gamble, cutting an estimated $1.39M.
- Quadrant Capital Group fully exited Yahoo Inc in Q2 2017, selling an estimated $130K.
- Quadrant Capital Group's ten largest holdings make up 22% of its $226M portfolio in Q2 2017.
- Quadrant Capital Group opened 104 new positions and closed 97 in Q2 2017.
- Quadrant Capital Group's portfolio value fell 0.6% quarter-over-quarter to $226M.
Based on Quadrant Capital Group's 13F filing for Q2 2017, filed 15 Aug 2017.